Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Chappell

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Clinical and Translational Science|March 13, 2024
In vitro PK/PD modeling of tyrosine kinase inhibitors in non-small cell lung cancer cell linesLinda Wanika, Neil D Evans, Martin Johnson, et al.
Journal of Pharmacological and Toxicological Methods|January 19, 2016
PKPD modelling of PR and QRS intervals in conscious dogs using standard safety pharmacology dataLinnéa Bergenholm, Teresa Collins, Neil D Evans, et al.
Mathematical Biosciences|November 7, 2017
Extending existing structural identifiability analysis methods to mixed-effects modelsDavid L I Janzén, Mats Jirstrand, Michael J Chappell, et al.
Computer Methods and Programs in Biomedicine|May 17, 2016
Three novel approaches to structural identifiability analysis in mixed-effects modelsDavid L I Janzén, Mats Jirstrand, Michael J Chappell, et al.
Frontiers in Immunology|April 27, 2019
Parameter Identification for a Model of Neonatal Fc Receptor-Mediated Recycling of Endogenous Immunoglobulin G in HumansFelicity Kendrick, Neil D Evans, Oscar Berlanga, et al.
Computer Methods and Programs in Biomedicine|July 23, 2013
Pharmacokinetic modelling of the anti-malarial drug artesunate and its active metabolite dihydroartemisininAdam J Hall, Michael J Chappell, John A D Aston, et al.
Healthcare Technology Letters|April 10, 2026
In-Vivo Hand Mass Determination and an Anthropometric Investigation on Segment Length and Radius for Prosthetic Segment DesignPanagiotis Tsakonas, Neil D Evans, Joseph Hardwicke, et al.
Computer Methods and Programs in Biomedicine|January 25, 2014
Reprint of "Pharmacokinetic modelling of the anti-malarial drug artesunate and its active metabolite dihydroartemisinin"Adam J Hall, Michael J Chappell, John A D Aston, et al.
Microbiology (Reading, England)|May 27, 2014
Observation of the time-course for peptidoglycan lipid intermediate II polymerization by Staphylococcus aureus monofunctional transglycosylaseDarren Braddick, Sandeep Sandhu, David I Roper, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 4, 2015
Dose-response-time modelling: Second-generation turnover model with integral feedback controlRobert Andersson, Mats Jirstrand, Lambertus Peletier, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Clinical and Translational Science|March 13, 2024
In vitro PK/PD modeling of tyrosine kinase inhibitors in non-small cell lung cancer cell linesLinda Wanika, Neil D Evans, Martin Johnson, et al.
Journal of Pharmacological and Toxicological Methods|January 19, 2016
PKPD modelling of PR and QRS intervals in conscious dogs using standard safety pharmacology dataLinnéa Bergenholm, Teresa Collins, Neil D Evans, et al.
Mathematical Biosciences|November 7, 2017
Extending existing structural identifiability analysis methods to mixed-effects modelsDavid L I Janzén, Mats Jirstrand, Michael J Chappell, et al.
Computer Methods and Programs in Biomedicine|May 17, 2016
Three novel approaches to structural identifiability analysis in mixed-effects modelsDavid L I Janzén, Mats Jirstrand, Michael J Chappell, et al.
Frontiers in Immunology|April 27, 2019
Parameter Identification for a Model of Neonatal Fc Receptor-Mediated Recycling of Endogenous Immunoglobulin G in HumansFelicity Kendrick, Neil D Evans, Oscar Berlanga, et al.
Computer Methods and Programs in Biomedicine|July 23, 2013
Pharmacokinetic modelling of the anti-malarial drug artesunate and its active metabolite dihydroartemisininAdam J Hall, Michael J Chappell, John A D Aston, et al.
Healthcare Technology Letters|April 10, 2026
In-Vivo Hand Mass Determination and an Anthropometric Investigation on Segment Length and Radius for Prosthetic Segment DesignPanagiotis Tsakonas, Neil D Evans, Joseph Hardwicke, et al.
Computer Methods and Programs in Biomedicine|January 25, 2014
Reprint of "Pharmacokinetic modelling of the anti-malarial drug artesunate and its active metabolite dihydroartemisinin"Adam J Hall, Michael J Chappell, John A D Aston, et al.
Microbiology (Reading, England)|May 27, 2014
Observation of the time-course for peptidoglycan lipid intermediate II polymerization by Staphylococcus aureus monofunctional transglycosylaseDarren Braddick, Sandeep Sandhu, David I Roper, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 4, 2015
Dose-response-time modelling: Second-generation turnover model with integral feedback controlRobert Andersson, Mats Jirstrand, Lambertus Peletier, et al.
Pageof 4